These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32354416)

  • 21. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.
    Gandhi PU; Gaggin HK; Redfield MM; Chen HH; Stevens SR; Anstrom KJ; Semigran MJ; Liu P; Januzzi JL
    JACC Heart Fail; 2016 Nov; 4(11):860-869. PubMed ID: 27744089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
    Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
    J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.
    Ferreira JP; Packer M; Sattar N; Butler J; González Maldonado S; Panova-Noeva M; Sumin M; Masson S; Pocock SJ; Anker SD; Zannad F; Januzzi JL
    Eur J Heart Fail; 2024 Apr; 26(4):806-816. PubMed ID: 38587259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
    Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
    Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
    Murray H; Cload B; Collier CP; Sivilotti ML
    CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
    Januzzi JL; Packer M; Claggett B; Liu J; Shah AM; Zile MR; Pieske B; Voors A; Gandhi PU; Prescott MF; Shi V; Lefkowitz MP; McMurray JJV; Solomon SD
    Circ Heart Fail; 2018 Oct; 11(10):e005133. PubMed ID: 30354399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure
.
    Charmetant X; Pecquet M; Poirié P; Agi D; Aupetit JF; Villar E
    Clin Nephrol; 2019 Aug; 92(2):65-72. PubMed ID: 31198167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.
    Behnes M; Brueckmann M; Lang S; Espeter F; Weiss C; Neumaier M; Ahmad-Nejad P; Borggrefe M; Hoffmann U
    Eur J Heart Fail; 2013 Dec; 15(12):1390-400. PubMed ID: 23851388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 35. IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study.
    Meessen JMTA; Cesaroni G; Mureddu GF; Boccanelli A; Wienhues-Thelen UH; Kastner P; Ojeda-Fernandez L; Novelli D; Bazzoni G; Mangiavacchi M; Agabiti N; Masson S; Staszewsky L; Latini R;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):328. PubMed ID: 34217226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community.
    Whalley GA; Wright SP; Pearl A; Gamble GD; Walsh HJ; Richards M; Doughty RN
    Eur Heart J; 2008 Feb; 29(4):509-16. PubMed ID: 18276620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.
    Velibey Y; Golcuk Y; Golcuk B; Oray D; Atilla OD; Colak A; Kurtulmus Y; Erbay AR; Yilmaz A; Eren M
    Am J Emerg Med; 2013 Dec; 31(12):1634-7. PubMed ID: 24055249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
    Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
    Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.